Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomic Modulation in Takotsubo Syndrome

NCT03324529 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT03324529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03324529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomic Modulation in Takotsubo Syndrome
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 1, 2021
Completion date
June 30, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

takotsubo syndrome